Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Ophthalmology

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Myopia Clinical Trials

A listing of Myopia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (57) clinical trials

Effectiveness of Orthokeratology in Myopia Control

Orthokeratology (ortho-k), when used for partial or full correction of myopia, has been shown to slow myopic progression in children by 36-56% as compared to their spectacle or contact-lens wearing peers.1 This effect is achieved by limiting the axial elongation of the eye,1, 2,3, 4 which is of particular concern ...

Phase N/A

Investigating the Effect of Using Myopia Prediction Algorithm on Myopia Children

We propose to enroll myopia children aged 8-10 in China. Children will be given examinations of visual acuity, eye refraction and biometrics, and be assigned to two groups: participants in group A use myopia prediction algorithm to predict myopia development, while in Group B, the participants do not use myopia ...

Phase N/A

Effect of Using Myopia Prediction Algorithm on Myopia School-aged Children

The investigators propose to enroll myopia children aged 8-10 in China. Children will be given examinations of visual acuity, eye refraction and biometrics, and be assigned to two groups: participants in group A use myopia prediction algorithm to predict myopia development, while in Group B, the participants do not use ...

Phase N/A

Evaluation of Cataract Surgery Outcome

The purpose of this study is to evaluate the visual outcome of the cataract surgery, including best uncorrected and corrected visual acuity, spherical equivalent, wavefront aberration and other measurements.

Phase N/A

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

The purpose of this study is to determine the effectiveness of antiangiogenic therapy to choroidal neovascularization secondary to pathologic myopia. This study is planned as a follow-up. Patients with myopia included in it will receive antiangiogenic therapy in accordance with the approved indications for use indicated in the instructions for ...

Phase N/A

Alcohol Myopia Objectification and Sexual Assault

These studies will provide a comprehensive test of our proposed model of alcohol-involved sexual assault that includes situation-specific mechanisms and key moderators of sexual violence. Specifically, hypotheses will be tested in the context of two carefully controlled laboratory studies. In Study 1, laboratory alcohol administration procedures will be used to ...

Phase N/A

Effectiveness of Myopia Control by Breath-O Correct Orthokeratology Lenses

Myopia is the most common refractive error in the world. In Hong Kong, the number of children in myopia is on the rise and approximately 80% of children are myopic by the end of childhood. Orthokeratology is one of the most successful myopia control methods adopting the strategy of peripheral ...

Phase N/A

Atropine 0.01% Eye Drops in Myopia Study

To assess the efficacy and safety of using 0.01% atropine eye drops in reducing the progression of myopia in Omani population. Objectives To compare the effect of 0.01% atropine eye drops on progression of myopic refractive error and axial length with that in the control group. To study the effect ...

Phase N/A

Variation of Orthokeratology Lens Treatment Zone (VOLTZ) Study

Orthokeratology (Ortho-k) treatment reduces the degree of myopia of the eye by flattening the central cornea. This central flattened zone is referred to as the treatment zone (TZ). Munnerlyn's formula describes the negative correlation between refractive correction and treatment zone size given a maximum ablation depth limited by the patient's ...

Phase N/A

VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia

Laser refractive surgery (LASIK and PRK) has been established for 25 years to treat myopia (short-sightedness). Over this time, the technology has been significantly improved to enable safe treatment of myopia up to -15D. Improvements including changing the shape of the lens of corneal tissue removed to better match the ...

Phase N/A